|
Erectile Dysfunction Drugs in Japan: Marketing Issues and StrategiesPublished by: Decision Resources Published: Dec. 29, 2005 - 12 Pages The price of this publication has been reduced due to age. The full price was $1,900.Table of Contents
AbstractJapan--the second largest single-country pharmaceutical market in the world--represents a very large and relatively untapped erectile dysfunction (ED) therapeutic market. After providing an overview of the ED landscape in Japan, this report examines why promotional campaigns for the ED drugs available in Japan have failed to generate the level of sales that would be expected given ED therapies’ track record in other markets and the potential patient population in Japan. We hypothesize that, instead of helping alleviate any stigma attached to ED in Japan, manufacturers’ campaigns have actually exacerbated the challenge.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||